Pier Ferruccio Ballerini

Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia

Carlo Salvarani, Giovanni Dolci, Marco Massari et al. · JAMA Internal Medicine · 2020 · 733 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma

Gaetano Corazzelli, Gaetana Capobianco, Manuela Arcamone et al. · Cancer Chemotherapy and Pharmacology · 2009 · 76 citations

Medicine, Oncology, Pharmacology +14

Analysis of IgV_H gene mutations in B cell chronic lymphocytic leukaemia according to antigen‐driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery

Massimo Degan, Riccardo Bomben, Michele Dal Bo et al. · British Journal of Haematology · 2004 · 60 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Mutational Status of IgVH Genes Consistent with Antigen-Driven Selection but Not Percent of Mutations Has Prognostic Impact in B-Cell Chronic Lymphocytic Leukemia

Massimo Degan, Maurizio Rupolo, Michele Dal Bo et al. · Clinical Lymphoma · 2004 · 10 citations

Life Sciences, Genetics, Oncology +12